Stock GNPX GENPREX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Genprex, Inc.

Equities

GNPX

US3724462037

Real-time Estimate Cboe BZX
Other stock markets
 18:08:43 03/06/2024 BST 		5-day change 1st Jan Change
3.335 USD +7.23% Intraday chart for Genprex, Inc. +55.18% -64.24%
05-15 Genprex, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-14 Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa Immunogene Therapy in Combination with Tecentriq to Treat Small Cell Lung Cancer CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
GENPREX, INC.
Bio Therapeutic Drugs
+5.79%+55.18%-64.24%-91.33%-94.69% 6.52M
Neutral
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. GNPX Stock
  4. Charts Genprex, Inc.
  5. Relative Strength Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW